patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Re: Pluristem last trade at $4.79 in Berlin opend at $4.79 also

Re: Pluristem last trade at $4.79 in Berlin opend at $4.79 also

posted on May 06, 2008 11:48AM

Like Emma said would happen did just she said. The stock price went down

on exceptionally good news. FDA starting to take notice!

Isn't that good news?

Manolo,

Share
New Message
Please login to post a reply